Evidence map›Paper›PMID 23124208›Full record

ArticleThe Journal of biological chemistry2012

cAMP-responsive element modulator α (CREMα) contributes to decreased Notch-1 expression in T cells from patients with active systemic lupus erythematosus (SLE).

Thomas Rauen, Alexandros P Grammatikos, Christian M Hedrich, Jürgen Floege, Klaus Tenbrock, Kim Ohl, Vasileios C Kyttaris, George C Tsokos

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. [Effect of aberrant H3K27me3 modification in promoter regions on cAMP response element modulator α expression in CD4Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2017
    Article
  14. Article
  15. Epigenetics in SLE.Current rheumatology reports · 2017
    Review
  16. Review
  17. SLE-Associated Defects Promote Altered T Cell Function.Critical reviews in immunology · 2017
    Review
  18. Correlation of Notch1/Hes1 Genes Expression Levels in Egyptian Paediatric Patients with Newly Diagnosed and Persistent Primary Immune(Idiopathic) Thrombocytopenic Purpura.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Thomas RauenDivision of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA.
Alexandros P Grammatikos
Christian M Hedrich
Jürgen Floege
Klaus Tenbrock
Kim Ohl
Vasileios C Kyttaris
George C Tsokos
Beth Israel Deaconess Medical Center · USRWTH Aachen University · DEHarvard University · US

Funding

Expanded Double Negative T cells in SLE.R01AI085567 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TSOKOS, GEORGE C · 2010 to 2025
$6.8M
LYMPHOCYTE SIGNALING DEFECTS IN PATIENTS WITH LUPUSR01AI042269 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI TSOKOS, GEORGE C · 1998 to 2017
$6.8M
Gene Transcription In SLER01AI049954 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI George C Tsokos · 2002 to 2026
$5.8M
The Role of Interleukin 23 in LupusR01AR060849 · NIAMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KYTTARIS, VASILEIOS CHRISTOS · 2012 to 2016
$1.9M
NIAID NIH HHS R01 AI042269NIAID NIH HHS R01 AI049954NIAID NIH HHS R01 AI085567NIAID NIH HHS R01 AI42269NIAID NIH HHS R01 AI49954NIAID NIH HHS R01 AI85567NIAMS NIH HHS R01 AR060849
6 · The paper itself

Abstract

Notch signaling constitutes an evolutionarily conserved pathway that transduces signals between neighboring cells and determines major decisions in cell proliferation, survival, and differentiation. Notch signaling has been shown to play a pivotal role during T cell lineage determination. T lymphocytes from patients with systemic lupus erythematosus (SLE) display a severely altered phenotype with several molecular and functional aberrations, including defective capacities to up-regulate Notch-1 receptor expression upon T cell receptor activation. Here, we demonstrate that basal Notch-1 expression is decreased in T cells from active SLE patients at the mRNA and protein levels in various T cell subpopulations. Notch-1 transcript numbers inversely correlate with disease activity in SLE patients. We provide evidence that both enhanced histone H3 methylation and CpG DNA methylation of the human Notch-1 promoter contribute to decreased Notch-1 expression in SLE T cells. Previous data from our group identified cAMP-responsive element modulator α (CREMα), which is up-regulated in SLE T cells, as a key regulator of epigenetic patterns and gene transcription, e.g. that of IL2 and IL17 genes. In this study, we observed increased CREMα binding to the Notch-1 promoter, which eventually resulted in significantly reduced Notch-1 promoter activity and gene transcription. Notably, decreased Notch-1 levels were associated with elevated IL-17A levels. Our data suggest a role for Notch-1 in SLE immunopathogenesis, and for the first time, we present molecular mechanisms that mediate dysregulated Notch-1 expression in SLE T cells.

Indexed as

Gene Expression RegulationAnimalsCase-Control StudiesCell MembraneCpG IslandsCyclic AMP Response Element ModulatorDNA MethylationFemaleHistonesHumansInterleukin-17Jurkat CellsLupus Erythematosus, SystemicMicePromoter Regions, GeneticProtein BindingCREM protein, humanCyclic AMP Response Element ModulatorHistonesInterleukin-17NOTCH1 protein, humanReceptor, Notch1RNA, Messenger

Identifiers

PMID23124208
PMCPMC3522254
OpenAlexW2143973426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.